Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Puma Biotechnology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.03 | -$0.01 | -$0.02 |
| Q2 2025 | 1 | $0.14 | $0.14 | $0.14 |
| Q3 2025 | 1 | $0.11 | $0.11 | $0.11 |
| Q4 2025 | 1 | $0.17 | $0.17 | $0.17 |
Puma Biotechnology, Inc. Earnings Date And Information
Puma Biotechnology, Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.1 by $0.33. The company had revenue of 59.08 M for the quarter and had revenue of 230.47 M for the year. Puma Biotechnology, Inc. has generated $1 earnings per share over the last year ($0.62 diluted earnings per share) and currently has a price-to-earnings ratio of 4.7. Puma Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based on prior year's report dates.
Puma Biotechnology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 2024 | $0.10 | $0.39 | 0.29 | $52.51 M | $59.08 M |
| 11/07/2024 | Q3 2024 | $0.35 | $0.41 | 0.06 | $70.65 M | $80.54 M |
| 08/01/2024 | Q2 2024 | -$0.10 | -$0.09 | 0.01 | $44.70 M | $47.08 M |
| 05/02/2024 | Q1 2024 | -$0.16 | -$0.10 | 0.06 | $41.05 M | $43.77 M |
| 02/29/2024 | Q4 2023 | $0.30 | $0.26 | -0.04 | $73.55 M | $72.18 M |
| 11/02/2023 | Q3 2023 | $0.08 | $0.12 | 0.04 | $57.95 M | $56.12 M |
| 08/03/2023 | Q2 2023 | $0.07 | $0.05 | -0.02 | $51.73 M | $54.57 M |
| 05/04/2023 | Q1 2023 | $0.04 | $0.03 | -0.01 | N/A | $52.78 M |
| 03/02/2023 | Q4 2022 | $0.06 | -$0.12 | -0.18 | N/A | $65.70 M |
| 11/03/2022 | Q3 2022 | -$0.11 | -$0.01 | 0.1 | $50.47 M | $57.10 M |
| 08/04/2022 | Q2 2022 | $0.00 | $0.21 | 0.21 | $52.62 M | $59.52 M |
| 05/05/2022 | Q1 2022 | -$0.13 | -$0.08 | 0.05 | N/A | $45.74 M |
| 03/03/2022 | Q4 2021 | -$0.09 | $0.10 | 0.19 | N/A | $55.40 M |
| 11/04/2021 | Q3 2021 | -$0.23 | -$1.09 | -0.86 | $53.33 M | $46.25 M |
| 08/05/2021 | Q2 2021 | -$0.31 | -$0.13 | 0.18 | $53.14 M | $53.38 M |
| 05/06/2021 | Q1 2021 | $0.09 | $0.41 | 0.32 | N/A | $98.17 M |
| 03/01/2021 | Q4 2020 | N/A | -$0.38 | N/A | N/A | $52.60 M |
| 11/05/2020 | Q3 2020 | -$0.33 | -$0.79 | -0.46 | $52.97 M | $50.75 M |
| 08/06/2020 | Q2 2020 | -$0.30 | $0.09 | 0.39 | $57.61 M | $70.58 M |
| 05/07/2020 | Q1 2020 | -$0.79 | -$0.43 | 0.36 | N/A | $51.22 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Puma Biotechnology, Inc. Earnings: FAQ's
Puma Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based offlast year's report dates.
In the previous quarter, Puma Biotechnology, Inc. (:PBYI) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.1 by $0.33.
The conference call for Puma Biotechnology, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Puma Biotechnology, Inc.'s latest earnings report can be read online.
Puma Biotechnology, Inc. (:PBYI) has a recorded annual revenue of $230.47 M.
Puma Biotechnology, Inc. (:PBYI) has a recorded net income of $30.28 M.Puma Biotechnology, Inc. has generated $0.62 earnings per share over the last four quarters.
Puma Biotechnology, Inc. (:PBYI) has a price-to-earnings ratio of 4.7 and price/earnings-to-growth ratio is 0.17.